HUTCHMED (China) (HCM) Enterprise Value (2014 - 2026)
HUTCHMED (China) (HCM) posted quarterly Enterprise Value of -$1.4 billion for Q2 2026, down 0.66% year-over-year from -$1.4 billion in Q2 2025, and down 681.59% quarter-over-quarter from -$174.1 million in Q4 2025.
HUTCHMED (China) (HCM) Enterprise Value (2014 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Enterprise Value for 13 consecutive years, with -$1.4 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Enterprise Value fell 0.66% year-over-year to -$1.4 billion; the TTM figure through Jun 2026 stood at -$1.4 billion (down 0.66% YoY), while the FY2025 annual figure was -$174.1 million, down 64.81% from the prior year.
- Enterprise Value declined to -$1.4 billion in Q2 2026 per HCM's latest filing, from -$174.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at $1.6 billion in Q4 2023 and bottomed at -$1.4 billion in Q2 2026.
- Historically, Enterprise Value has averaged -$425.4 million across 5 years, with a median of -$774.1 million in 2022.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 2227.31% — and 2024, when it slumped 106.45%.
- HUTCHMED (China)'s Enterprise Value stood at -$77.3 million in 2022, then jumped by 2227.31% to $1.6 billion in 2023, then slumped by 106.45% to -$106.0 million in 2024, then tumbled by 64.21% to -$174.1 million in 2025, then sank by 681.59% to -$1.4 billion in 2026.
- Business Quant data shows HCM's Enterprise Value at -$1.4 billion in Q2 2026, -$174.1 million in Q4 2025, and -$1.4 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | -1.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.36 Bn |
| Dec 31, 2025 | -174.08 Mn |
| Jun 30, 2025 | -1.35 Bn |
| Dec 31, 2024 | -106.02 Mn |
| Jun 30, 2024 | -790.52 Mn |
| Dec 31, 2023 | 1.64 Bn |
| Jun 30, 2023 | -838.19 Mn |
| Dec 31, 2022 | -77.28 Mn |
| Jun 30, 2022 | -774.08 Mn |
| Dec 31, 2021 | -123.12 Mn |
| Jun 30, 2021 | -921.55 Mn |
| Mar 31, 2021 | -359.95 Mn |
| Dec 31, 2020 | -435.18 Mn |
| Jun 30, 2020 | -256.09 Mn |
| Dec 31, 2019 | -217.17 Mn |
| Sep 30, 2019 | -177.31 Mn |
| Jun 30, 2019 | -212.14 Mn |
| Mar 31, 2019 | -247.28 Mn |
| Dec 31, 2018 | -277.69 Mn |
| Jun 30, 2018 | -296.38 Mn |